655 related articles for article (PubMed ID: 31102154)
1. Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy.
Le QV; Suh J; Oh YK
AAPS J; 2019 May; 21(4):64. PubMed ID: 31102154
[TBL] [Abstract][Full Text] [Related]
2. Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies.
Liu Y; Guo J; Huang L
Theranostics; 2020; 10(7):3099-3117. PubMed ID: 32194857
[TBL] [Abstract][Full Text] [Related]
3. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
[TBL] [Abstract][Full Text] [Related]
5. Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment.
Sun B; Hyun H; Li LT; Wang AZ
Acta Pharmacol Sin; 2020 Jul; 41(7):970-985. PubMed ID: 32424240
[TBL] [Abstract][Full Text] [Related]
6. Recent progress in nanomaterials for nucleic acid delivery in cancer immunotherapy.
Mei Y; Wang R; Jiang W; Bo Y; Zhang T; Yu J; Cheng M; Wu Y; Cheng J; Ma W
Biomater Sci; 2019 Jun; 7(7):2640-2651. PubMed ID: 31090764
[TBL] [Abstract][Full Text] [Related]
7. Nanomaterials in modulating tumor-associated macrophages and enhancing immunotherapy.
Liang C; Zhang Y; Wang S; Jiao W; Guo J; Zhang N; Liu X
J Mater Chem B; 2024 May; 12(20):4809-4823. PubMed ID: 38695349
[TBL] [Abstract][Full Text] [Related]
8. Engineered Nanomaterials for Tumor Immune Microenvironment Modulation in Cancer Immunotherapy.
Xing H; Li X
Chemistry; 2024 Jun; 30(32):e202400425. PubMed ID: 38576219
[TBL] [Abstract][Full Text] [Related]
9. Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy.
Phuengkham H; Ren L; Shin IW; Lim YT
Adv Mater; 2019 Aug; 31(34):e1803322. PubMed ID: 30773696
[TBL] [Abstract][Full Text] [Related]
10. Carbon-Based Nanomaterials for Cancer Therapy via Targeting Tumor Microenvironment.
Saleem J; Wang L; Chen C
Adv Healthc Mater; 2018 Oct; 7(20):e1800525. PubMed ID: 30073803
[TBL] [Abstract][Full Text] [Related]
11. Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment.
Jin Y; Huang Y; Ren H; Huang H; Lai C; Wang W; Tong Z; Zhang H; Wu W; Liu C; Bao X; Fang W; Li H; Zhao P; Dai X
Biomaterials; 2024 Mar; 305():122463. PubMed ID: 38232643
[TBL] [Abstract][Full Text] [Related]
12. Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy.
Gao S; Yang D; Fang Y; Lin X; Jin X; Wang Q; Wang X; Ke L; Shi K
Theranostics; 2019; 9(1):126-151. PubMed ID: 30662558
[TBL] [Abstract][Full Text] [Related]
13. Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy.
Chen Z; Yue Z; Yang K; Shen C; Cheng Z; Zhou X; Li S
Adv Healthc Mater; 2023 Oct; 12(26):e2300882. PubMed ID: 37539730
[TBL] [Abstract][Full Text] [Related]
14. Nanomaterial-Based Drug Delivery Systems: A New Weapon for Cancer Immunotherapy.
Jiang Z; Zhang W; Zhang J; Liu T; Xing J; Zhang H; Tang D
Int J Nanomedicine; 2022; 17():4677-4696. PubMed ID: 36211025
[TBL] [Abstract][Full Text] [Related]
15. Nanomaterials for cancer immunotherapy.
Song W; Musetti SN; Huang L
Biomaterials; 2017 Dec; 148():16-30. PubMed ID: 28961532
[TBL] [Abstract][Full Text] [Related]
16. Nanomaterial-Based Tumor Photothermal Immunotherapy.
Xu P; Liang F
Int J Nanomedicine; 2020; 15():9159-9180. PubMed ID: 33244232
[TBL] [Abstract][Full Text] [Related]
17. Nanoenabled Tumor Oxygenation Strategies for Overcoming Hypoxia-Associated Immunosuppression.
Zhang C; Yan Q; Li J; Zhu Y; Zhang Y
ACS Appl Bio Mater; 2021 Jan; 4(1):277-294. PubMed ID: 35014284
[TBL] [Abstract][Full Text] [Related]
18. Tumor vasculature normalization by orally fed erlotinib to modulate the tumor microenvironment for enhanced cancer nanomedicine and immunotherapy.
Chen Q; Xu L; Chen J; Yang Z; Liang C; Yang Y; Liu Z
Biomaterials; 2017 Dec; 148():69-80. PubMed ID: 28968536
[TBL] [Abstract][Full Text] [Related]
19. Nanomaterials for T-cell cancer immunotherapy.
Gong N; Sheppard NC; Billingsley MM; June CH; Mitchell MJ
Nat Nanotechnol; 2021 Jan; 16(1):25-36. PubMed ID: 33437036
[TBL] [Abstract][Full Text] [Related]
20. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]